By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ortho Biotech Products, L.P. 

P.O. Box 6914
430 Rt. 22 East
Bridgewater  New Jersey  08807-0914  U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
Ortho Biotech Products, L.P. Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer 12/15/2008 6:33:36 AM
Ortho Biotech Products, L.P. Announces NDA Submission for Trabectedin for the Treatment of Relapsed Ovarian Cancer 11/20/2008 8:01:05 AM
Ortho Biotech Products, L.P. Release: Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 11/7/2008 11:26:06 AM
Ortho Biotech Products, L.P. Preliminary Data From Experimental Study Demonstrate Increased Mortality in Stroke Patients Treated With Epoetin Alfa 9/18/2008 10:28:51 AM
Ortho Biotech Products, L.P. Files sNDA for DOXIL(R) for the Treatment of Advanced Breast Cancer 9/8/2008 7:35:04 AM
Janssen-Cilag International NV (JNJ), Ortho Biotech Products, L.P. VELCADE(R) Approved For Previously Untreated Multiple Myeloma 9/8/2008 7:00:14 AM
Ortho Biotech Products, L.P. Announces Nationwide Voluntary Recall of Procrit(R) (Epoetin Alfa) Lot Number P114942A 8/5/2008 5:54:41 PM
Ortho Biotech Products, L.P. Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology Annual Meeting 5/30/2008 11:09:23 AM
Ortho Biotech Products, L.P. and Centocor, Inc. (JNJ) Alert Authorized Distributors and Prescribing Physicians About Stolen Product 5/15/2008 2:04:26 PM
Ortho Biotech Products, L.P. Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets 4/11/2008 10:13:49 AM
1234567
//-->